Caisse de depot et placement du Quebec
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 898286
Montreal, A8
Position in BMRN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$70,749,440
+$17,332,327 QoQ
Shares Held
1,236,446
+30.8% QoQ
Ownership
0.639%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#27
of 561 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caisse de depot et placement du Quebec holds $670,874,502 across 12 Biotechnology names. BMRN ranks #5 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
250,608 | $156,264,112 | |
| 2 | INCY |
Incyte Corp
|
1,370,503 | $155,360,220 | |
| 3 | EXEL |
Exelixis, Inc.
|
2,094,299 | $113,950,808 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,072,439 | $83,939,800 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
1,236,446 | $70,749,440 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,003,953 | $56,291,644 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
85,748 | $25,812,720 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
13,042 | $6,478,352 |
All Filings in BMRN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,749,440 | 1,236,446 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $53,417,113 | 945,603 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $62,332,620 | 1,048,841 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $49,456,908 | 913,163 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $35,030,676 | 637,269 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,019,928 | 56,867 | Shares | Sole | 2025-05-14 | |
| 2024-06-30 | $220,397 | 2,677 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,435,082 | 39,330 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,503,336 | 67,448 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,956,206 | 44,713 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,985,226 | 57,513 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,093,722 | 52,383 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,287,789 | 80,083 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,372,404 | 39,783 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,988,548 | 23,996 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,446,691 | 31,734 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $294,558 | 3,334 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $496,897 | 6,429 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $419,619 | 5,029 | Shares | Sole | 2021-08-13 | |
| 2020-09-30 | $213,024 | 2,800 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $542,696 | 4,400 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $452,075 | 5,350 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||